AI summary · may contain errors
Empirical tuberculosis treatment added to standard care did not reduce all-cause mortality versus a clinically and microbiologically guided strategy in 558 infants with severe HIV-associated pneumonia.
- Open access
Moving in Clinical Infectious Diseases, The Lancet Global Health, medRxiv, American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, The Lancet Infectious Diseases, mSystems and PLOS Medicine.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
Empirical tuberculosis treatment added to standard care did not reduce all-cause mortality versus a clinically and microbiologically guided strategy in 558 infants with severe HIV-associated pneumonia.
AI summary · may contain errors
In Mali’s LAKANA cluster trial, twice-yearly azithromycin for 1–11-month-old infants for 2 years did not increase macrolide resistance in Streptococcus pneumoniae at 36 months.
AI summary · may contain errors
In Novi Sad children aged 2–60 months (Oct 2022–Sep 2026), pneumococcal nasopharyngeal carriage prevalence was 27.0% (911/3,373), with diverse serotypes and notable antimicrobial resistance.
AI summary · may contain errors
A single-dose PCV mass-vaccination campaign in a displaced-people camp near Hargeisa, Somaliland, prevents 27% (95% CrI: 20, 34) of severe pneumococcal disease for up to 3 years when vaccinating children <5 years.
AI summary · may contain errors
Reduced-dosing PCV13 1+1 schedules (6w+1 or 14w+1) maintained non-inferior serotype-specific IgG GMC ratios versus PCV13 2+1 through age 5 years in South African infants.
AI summary · may contain errors
Clarithromycin is associated with more favourable outcomes than azithromycin for severe pertussis in hospitalised infants in Italy, with PSS >5 at 33% vs 60%.
AI summary · may contain errors
RSV vaccination in US Medicare fee-for-service nursing home residents was associated with 73% vaccine effectiveness against RSV-associated hospitalization during the first season.
AI summary · may contain errors
In 1052 children aged 2–59 months hospitalized with WHO-defined severe community-acquired pneumonia in the PediCAP trial, no risk score clearly outperformed WHO criteria for in-hospital mortality (ROC-AUC ~0.73–0.87).
AI summary · may contain errors
Real-world evidence shows RSV prevention products achieve high effectiveness across infants and older adults, including linked reductions in cardiovascular events in older adults.
AI summary · may contain errors
A graded, revisable ICU-acquired pneumonia assessment framework links detected organisms to the plausibility of causing current lung injury, using reassessment at 48–72 hours.
AI summary · may contain errors
Universal infant nirsevimab prophylaxis in the NIRSE-GAL study is linked to a sustained 55·3% reduction in RSV-related LRTI hospitalisations in the second season.
Journals this month
Topics moving, week to 17 Nov 2026
By field